Abstract

Abstract Background Endocrinologists often manipulate hormones by adding medication or replacing hormones that are no longer being produced. However, replacing hormones artificially causes hormone producing cells that are still viable to become suppressed and ultimately shut down. For example, with estrogen, testosterone, or cortisol replacements, the cells responsible for the production become inactive. This study tries to show that the same process affects the beta cells in the pancreas. The more insulin given, the further these beta cells become suppressed, and block natural insulin production. Rather than insulin resistance, our results showed that high dose artificial insulin inhibits the beta cells and prevents natural production. Methods To perform this study, we took a random sample of 13 type 2 diabetics on high doses of insulin. Prior to the study, they were taking over 20 units of bolus prandial insulin 3x daily, and over 50 units of basal insulin 1-2x daily. We reduced their insulin by half, monitored them closely, instructed them to change their lifestyle and follow a proper diabetic diet. Results Out of the 13 patients, 10 of them showed significant improvement on follow-up evaluation. The HbA1c and finger sticks had remained consistent or improved with the reduced dose. This showed the beta cells had been suppressed and were now becoming more responsive. Overall, the patients responded well to the reduction in their high doses of insulin, and it appeared that the pancreas’ beta cells began to naturally produce insulin. Conclusion The results showed that a lifestyle change along with the reduction in insulin was successful in treating patients with Type 2 Diabetes. Like any other hormone, prescribing large doses of insulin has been indirectly suppressing the action of beta cells. This suggests that patients may not be developing insulin resistance, rather their beta cells are losing their functionality. To control their Type 2 diabetes, patients should focus on pursuing a healthy lifestyle and lowering their insulin. Limitations to the study were that the threshold where the beta cells no longer function has not yet been quantified, and patient non-compliance with monitoring and lifestyle changes, resulting in the need for increased insulin. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.